DURECT Corp (DRRX)

• Market cap: $26.1M
• 1 day: -0.95%
• 5 days: 2.66%
• 1 month: -9.37%
• 3 months: -41.13%
• 6 months: -48.98%
• Year to date: 6.45%
• 1 year: 10.76%
• 5 years: -96.01%
• 10 years: -90.32%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

About: Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the Europe .

Employees: 58

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

170% more call options, than puts

Call options by funds: $254K | Put options by funds: $94K

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

0% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 12

2% less capital invested

Capital invested by funds: $9.71M [Q2] → $9.5M (-$209K) [Q3]

1.33% less ownership

Funds ownership: 24.25% [Q2] → 22.92% (-1.33%) [Q3]

4% less funds holding

Funds holding: 45 [Q2] → 43 (-2) [Q3]

100% less funds holding in top 10

Funds holding in top 10: 1 [Q2] → 0 (-1) [Q3]